leisure time -WSS

leisure time

author：comprehensive 2025-09-30 18:48:02 - browse：8716

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Senate panel puts off hardest PBM reforms for another day

focus

WSS

GSK’s asthma push continues as drug succeeds in Phase 3 trials

STAT Report: Patient voices and perspectives

How doctors’ personal politics affect patients

Warren pushes Witty on UnitedHealth's control over physicians

Black vets could get higher VA benefits if race not used in lung test

Has Bernie Sanders reached the limit of his pharma bullying effort?

knowledge

leisure time

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Democrats decry new health bill for going easy on private equity

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The effects of a landmark ruling on DNA ownership are becoming clearer

The cancer drug shortage isn’t new — and neither are the solutions

Most antidepressants don't work on kids, teens, study finds

Bright Health sells Medicare Advantage business to Molina

Biogen says it will cut costs by $700 million, slash 1,000 jobs

At least 13 dead in Texas as scorching temps continue

Search called off for baby washed away in Pennsylvania flash flood

focus

STAT Report: Patient voices and perspectives

The haunting brain science of long Covid

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Former reverend arrested for allegedly killing 8

New Alzheimer's drugs heat up race for early detection blood tests

New Alzheimer's drugs heat up race for early detection blood tests

knowledge

focus

hotspot

hotspot